News
2h
Verywell Health on MSNLilly’s Oral GLP-1 Drug Shows Modest Weight Loss Results Compared to Injectables
People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, ...
A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain ...
Primary packaging is never an afterthought in the world of injectable drugs, where systems such as vials, syringes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results